- Investopedia•7 hours ago
Some large drug companies are working hard to develop a treatment that could generate a big payout.
- GlobeNewswire•12 hours ago
Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment ...
- Investopedia•3 days ago
Safety concerns have re-emerged after a patient died in Roche’s hemophilia trial.
SHP.L : Summary for SHIRE PLC ORD 5P - Yahoo Finance
Shire plc (SHP.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||4,843.50 x 51000|
|Ask||4,875.00 x 53800|
|Day's Range||4,822.00 - 4,896.50|
|52 Week Range||2,707.19 - 5,377.00|
|PE Ratio (TTM)||117.71|
|Dividend & Yield||0.26 (0.43%)|
|1y Target Est||N/A|